NCT01931644Completed
At-Home Research Study for Patients With Autoimmune, Inflammatory, Genetic, Hematological, Infectious, Neurological, CNS, Oncological, Respiratory, Metabolic Conditions
A Multi-Site Tissue Repository Providing Annotated Biospecimens for Approved Investigator-Directed Biomedical Research Initiatives
Source: ClinicalTrials.gov · Last updated 18 Apr 2024 · Not updated for over 12 months - ask the site whether it is still open
Brief summary (registry, in English)
We are the missing link in clinical trials, connecting patients and researchers seamlessly and conveniently using a mobile health platform to advance medical research. We make it easy for patients to contribute to research for medical conditions that matter most to them, regardless of their location or ability to travel.
- Status (registry)
- Completed
- Study type
- Observational
- Enrollment
- 17667 (actual)
- First submitted
- 23 Aug 2013
- Start date
- 1 Jul 2013
- Primary completion date
- 30 Apr 2024
- Lead sponsor
- Sanguine Biosciences
- Diseases
- Prostate cancer, Melanoma, Kidney cancer, Cervical cancer, Huntington's disease, Epilepsy, Spinal muscular atrophy, CIDP (chronic inflammatory demyelinating polyneuropathy), Bipolar disorder, Lung cancer, Pancreatic cancer, Colorectal cancer, Parkinson disease, Multiple myeloma, Ovarian cancer, Multiple sclerosis, Chronic kidney disease, Polycystic kidney disease, Crohn's disease, Ulcerative colitis, Asthma, COPD, Cystic fibrosis, Rheumatoid arthritis, Lupus (SLE), Psoriasis, Psoriatic arthritis, Ankylosing spondylitis, Atopic dermatitis (eczema), Systemic sclerosis (scleroderma), Sjögren's disease, Duchenne muscular dystrophy, Sickle cell disease, Thalassaemia, HIV, Hepatitis B, Endometriosis
- NCT number
- NCT01931644
What you commit to
- Study type: Observational
- Participants enrolled: 17667
- From 1 Jul 2013 to the primary completion date, 30 Apr 2024
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Receipt of investigational drug within 30 days of study blood collection
Age
- Younger than 18 years old
Other
- Receipt of blood products within 30 days of study blood collection
Who the study is looking for
- All adults 18-100 years old
- Able to provide proof of diagnosis
- Live in USA
Age in the registry: 18 years to 100 years · Sex: All · Accepts healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Sanguine Biosciences Coordinator of this site? Confirm its status | Los Angeles | United States | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.